Although the intra-tumor concentration of doxorubicin in JC tumors is very low [45], such concentration was sufficient to increase HIF-1α and up-regulate Pgp levels, glycolytic genes levels, glucose uptake and metabolism through glycolysis and TCA cycle. The gene discussed is HIF1A; the disease is neoplasm.